Current Environment: Production

Christelle Moufawad El Achkar | Medical Services

Specialties

Programs & Services

Languages

  • English

Christelle Moufawad El Achkar | Education

Medical School

American University of Beirut

2008, Riad El Solh, Beirut

Internship

Rainbow Babies & Children's Hospital

2011, Cleveland, OH

Residency

Boston Children's Hospital

2014, Boston, MA

Fellowship

Boston Children's Hospital

2016, Boston, MA

Christelle Moufawad El Achkar | Certifications

  • American Board of Psychiatry and Neurology (Child and Adolescent Neurology)
  • American Board of Psychiatry and Neurology (Epilepsy)

Christelle Moufawad El Achkar | Publications

  1. Utility of Exome Sequencing for Diagnosis in Unexplained Pediatric-Onset Epilepsy. JAMA Netw Open. 2023 07 03; 6(7):e2324380. View Utility of Exome Sequencing for Diagnosis in Unexplained Pediatric-Onset Epilepsy. Abstract

  2. Clinical Characteristics of Seizures and Epilepsy in Individuals With Recurrent Deletions and Duplications in the 16p11.2 Region. Neurol Genet. 2022 Oct; 8(5):e200018. View Clinical Characteristics of Seizures and Epilepsy in Individuals With Recurrent Deletions and Duplications in the 16p11.2 Region. Abstract

  3. Human ARHGEF9 intellectual disability syndrome is phenocopied by a mutation that disrupts collybistin binding to the GABAA receptor a2 subunit. Mol Psychiatry. 2022 Mar; 27(3):1275. View Human ARHGEF9 intellectual disability syndrome is phenocopied by a mutation that disrupts collybistin binding to the GABAA receptor a2 subunit. Abstract

  4. Human ARHGEF9 intellectual disability syndrome is phenocopied by a mutation that disrupts collybistin binding to the GABAA receptor a2 subunit. Mol Psychiatry. 2022 03; 27(3):1729-1741. View Human ARHGEF9 intellectual disability syndrome is phenocopied by a mutation that disrupts collybistin binding to the GABAA receptor a2 subunit. Abstract

  5. De novo TRIM8 variants impair its protein localization to nuclear bodies and cause developmental delay, epilepsy, and focal segmental glomerulosclerosis. Am J Hum Genet. 2021 02 04; 108(2):357-367. View De novo TRIM8 variants impair its protein localization to nuclear bodies and cause developmental delay, epilepsy, and focal segmental glomerulosclerosis. Abstract

  6. Characterization of the GABRB2-Associated Neurodevelopmental Disorders. Ann Neurol. 2021 03; 89(3):573-586. View Characterization of the GABRB2-Associated Neurodevelopmental Disorders. Abstract

  7. Polymicrogyria is Associated With Pathogenic Variants in PTEN. Ann Neurol. 2020 12; 88(6):1153-1164. View Polymicrogyria is Associated With Pathogenic Variants in PTEN. Abstract

  8. Genetic diagnoses in epilepsy: The impact of dynamic exome analysis in a pediatric cohort. Epilepsia. 2020 02; 61(2):249-258. View Genetic diagnoses in epilepsy: The impact of dynamic exome analysis in a pediatric cohort. Abstract

  9. Clinical Reasoning: A 6-week-old infant with migrating focal seizures. Neurology. 2020 01 28; 94(4):178-183. View Clinical Reasoning: A 6-week-old infant with migrating focal seizures. Abstract

  10. Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease. N Engl J Med. 2019 10 24; 381(17):1644-1652. View Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease. Abstract

  11. Heterogeneous clinical and functional features of GRIN2D-related developmental and epileptic encephalopathy. Brain. 2019 10 01; 142(10):3009-3027. View Heterogeneous clinical and functional features of GRIN2D-related developmental and epileptic encephalopathy. Abstract

  12. Recurrent SLC1A2 variants cause epilepsy via a dominant negative mechanism. Ann Neurol. 2019 06; 85(6):921-926. View Recurrent SLC1A2 variants cause epilepsy via a dominant negative mechanism. Abstract

  13. De Novo Pathogenic Variants in CACNA1E Cause Developmental and Epileptic Encephalopathy with Contractures, Macrocephaly, and Dyskinesias. Am J Hum Genet. 2019 Mar 07; 104(3):562. View De Novo Pathogenic Variants in CACNA1E Cause Developmental and Epileptic Encephalopathy with Contractures, Macrocephaly, and Dyskinesias. Abstract

  14. De Novo Pathogenic Variants in CACNA1E Cause Developmental and Epileptic Encephalopathy with Contractures, Macrocephaly, and Dyskinesias. Am J Hum Genet. 2018 11 01; 103(5):666-678. View De Novo Pathogenic Variants in CACNA1E Cause Developmental and Epileptic Encephalopathy with Contractures, Macrocephaly, and Dyskinesias. Abstract

  15. A Recurrent De Novo PACS2 Heterozygous Missense Variant Causes Neonatal-Onset Developmental Epileptic Encephalopathy, Facial Dysmorphism, and Cerebellar Dysgenesis. Am J Hum Genet. 2018 10 04; 103(4):631. View A Recurrent De Novo PACS2 Heterozygous Missense Variant Causes Neonatal-Onset Developmental Epileptic Encephalopathy, Facial Dysmorphism, and Cerebellar Dysgenesis. Abstract

  16. A Recurrent De Novo PACS2 Heterozygous Missense Variant Causes Neonatal-Onset Developmental Epileptic Encephalopathy, Facial Dysmorphism, and Cerebellar Dysgenesis. Am J Hum Genet. 2018 05 03; 102(5):995-1007. View A Recurrent De Novo PACS2 Heterozygous Missense Variant Causes Neonatal-Onset Developmental Epileptic Encephalopathy, Facial Dysmorphism, and Cerebellar Dysgenesis. Abstract

  17. PCDH19-related epilepsy is associated with a broad neurodevelopmental spectrum. Epilepsia. 2018 03; 59(3):679-689. View PCDH19-related epilepsy is associated with a broad neurodevelopmental spectrum. Abstract

  18. Characterization of a novel variant in siblings with Asparagine Synthetase Deficiency. Mol Genet Metab. 2018 03; 123(3):317-325. View Characterization of a novel variant in siblings with Asparagine Synthetase Deficiency. Abstract

  19. Compound heterozygosity with PRRT2: Pushing the phenotypic envelope in genetic epilepsies. Epilepsy Behav Case Rep. 2019; 11:125-128. View Compound heterozygosity with PRRT2: Pushing the phenotypic envelope in genetic epilepsies. Abstract

  20. A Model Program for Translational Medicine in Epilepsy Genetics. J Child Neurol. 2017 03; 32(4):429-436. View A Model Program for Translational Medicine in Epilepsy Genetics. Abstract

  21. De Novo TUBB2A Variant Presenting With Anterior Temporal Pachygyria. J Child Neurol. 2017 01; 32(1):127-131. View De Novo TUBB2A Variant Presenting With Anterior Temporal Pachygyria. Abstract

  22. SCN2A-Related Early-Onset Epileptic Encephalopathy Responsive to Phenobarbital. J Pediatr Epilepsy. 2016 Mar; 5(1):42-46. View SCN2A-Related Early-Onset Epileptic Encephalopathy Responsive to Phenobarbital. Abstract

  23. The genetics of the epilepsies. Curr Neurol Neurosci Rep. 2015 Jul; 15(7):39. View The genetics of the epilepsies. Abstract

  24. Clinical characteristics of children and young adults with co-occurring autism spectrum disorder and epilepsy. Epilepsy Behav. 2015 Jun; 47:183-90. View Clinical characteristics of children and young adults with co-occurring autism spectrum disorder and epilepsy. Abstract

  25. Genetic and phenotypic diversity of NHE6 mutations in Christianson syndrome. Ann Neurol. 2014 Oct; 76(4):581-93. View Genetic and phenotypic diversity of NHE6 mutations in Christianson syndrome. Abstract

  26. PRRT2-Associated Paroxysmal Movement Disorders. GeneReviews®. 1993. View PRRT2-Associated Paroxysmal Movement Disorders Abstract

BESbswy
BESbswy